Mortalin inhibitors sensitize K562 leukemia cells to complement-dependent cytotoxicity.

Source:http://linkedlifedata.com/resource/pubmed/id/19739077

Int. J. Cancer 2010 Mar 15 126 6 1428-35

Download in:

View as

General Info

PMID
19739077